Published in Eur J Cancer on May 02, 2006
Contemporary role of androgen deprivation therapy for prostate cancer. Eur Urol (2011) 2.68
Recommended patient-reported core set of symptoms to measure in prostate cancer treatment trials. J Natl Cancer Inst (2014) 1.42
Androgen deprivation therapy for the treatment of prostate cancer: consider both benefits and risks. Eur Urol (2008) 1.08
Intermittent androgen suppression for prostate cancer. Nat Rev Urol (2010) 1.01
Long-term dynamics of bone mineral density during intermittent androgen deprivation for men with nonmetastatic, hormone-sensitive prostate cancer. J Clin Oncol (2012) 0.95
A phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer. BMC Cancer (2009) 0.87
5α-reductase inhibition suppresses testosterone-induced initial regrowth of regressed xenograft prostate tumors in animal models. Endocrinology (2013) 0.83
A randomized controlled trial of an exercise intervention targeting cardiovascular and metabolic risk factors for prostate cancer patients from the RADAR trial. BMC Cancer (2009) 0.82
A randomized, phase II study of pazopanib in castrate-sensitive prostate cancer: a University of Chicago Phase II Consortium/Department of Defense Prostate Cancer Clinical Trials Consortium study. Prostate Cancer Prostatic Dis (2011) 0.82
Intermittent versus continuous androgen suppression therapy: do we have consensus yet? Curr Oncol (2010) 0.81
5α-Reductase inhibition coupled with short off cycles increases survival in the LNCaP xenograft prostate tumor model on intermittent androgen deprivation therapy. J Urol (2014) 0.80
Exercise therapy for sexual dysfunction after prostate cancer. Nat Rev Urol (2013) 0.79
Can exercise ameliorate treatment toxicity during the initial phase of testosterone deprivation in prostate cancer patients? Is this more effective than delayed rehabilitation? BMC Cancer (2012) 0.79
Sexuality and exercise in men undergoing androgen deprivation therapy for prostate cancer. Support Care Cancer (2014) 0.78
Influence of serum testosterone on urinary continence and sexual activity in patients undergoing radical prostatectomy for clinically localized prostate cancer. Prostate Cancer Prostatic Dis (2010) 0.77
Role of 5 alpha-reductase inhibitors in the management of prostate cancer. Clin Interv Aging (2006) 0.77
Quality of Life and Sexual Health in the Aging of PCa Survivors. Int J Endocrinol (2014) 0.77
Improving sexual health in men with prostate cancer: randomised controlled trial of exercise and psychosexual therapies. BMC Cancer (2014) 0.75
Relationships between times to testosterone and prostate-specific antigen rises during the first off-treatment interval of intermittent androgen deprivation are prognostic for castration resistance in men with nonmetastatic prostate cancer. Clin Genitourin Cancer (2014) 0.75
Gender Preference in the Sexual Attractions, Fantasies, and Relationships of Voluntarily Castrated Men. Sex Med (2016) 0.75
Language dominance in partial epilepsy patients identified with an fMRI reading task. Neurology (2002) 2.98
A simple index to predict prognosis independent of axillary node information in breast cancer. Aust N Z J Surg (1997) 2.71
Noninvasive assessment of language dominance in children and adolescents with functional MRI: a preliminary study. Neurology (1997) 2.55
Conformation of the gramicidin A transmembrane channel: A 13C nuclear magnetic resonance study of 13C-enriched gramicidin in phosphatidylcholine vesicles. J Mol Biol (1980) 2.36
Clinical significance of HER-2/neu oncogene amplification in primary breast cancer. The South Australian Breast Cancer Study Group. J Clin Oncol (1993) 2.15
Conformation of gramicidin A channel in phospholipid vesicles: a 13C and 19F nuclear magnetic resonance study. Proc Natl Acad Sci U S A (1979) 2.00
Restrictions on smoking at home and urinary cotinine levels among children with asthma. Am J Prev Med (2000) 1.81
P53 alteration and microsatellite instability have predictive value for survival benefit from chemotherapy in stage III colorectal carcinoma. Clin Cancer Res (2001) 1.74
Laparascopic excision of pelvic kidney with single vaginal ectopic ureter. J Pediatr Surg (1997) 1.56
Serum cholesterol and low-density lipoprotein cholesterol levels as predictors of response to interferon therapy for chronic hepatitis C. Ann Intern Med (2000) 1.55
Dissociation of immunologic and virologic responses to highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2000) 1.49
Risk factors for repeat attendance at hospital emergency departments among adults and children with asthma. Aust N Z J Med (1997) 1.48
Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma. Ann Allergy Asthma Immunol (1999) 1.46
Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial. Blood (1992) 1.45
Accelerated BEP for metastatic germ cell tumours: a multicenter phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP). Ann Oncol (2014) 1.44
Apoplectic headache and oculomotor nerve palsy: an unusual presentation of multiple sclerosis. Neurology (1990) 1.43
fMRI language task panel improves determination of language dominance. Neurology (2004) 1.43
Critical review of complementary therapies in haemato-oncology. Intern Med J (2006) 1.42
A cost-utility approach to the use of 5-fluorouracil and levamisole as adjuvant chemotherapy for Dukes' C colonic carcinoma. Med J Aust (1993) 1.41
Hip fracture rates in South Australia: into the next century. Aust N Z J Surg (2000) 1.38
Outcomes and predicting response in anaemic chemotherapy patients treated with epoetin alfa. A multicentre, 4-month, open-label study in Australia and New Zealand. Intern Med J (2008) 1.38
Elevated levels of versican but not decorin predict disease progression in early-stage prostate cancer. Clin Cancer Res (1998) 1.33
Cranio-carop-tarsal dysplasia or the whistling face syndrome. I. Clinical considerations. Am J Dis Child (1969) 1.31
A simple index using video image analysis to predict disease outcome in primary breast cancer. Int J Cancer (1999) 1.31
Testing sensibility, including touch-pressure, two-point discrimination, point localization, and vibration. J Hand Ther (1993) 1.26
Crystallographic studies on the ribosome, a large macromolecular assembly exhibiting severe nonisomorphism, extreme beam sensitivity and no internal symmetry. Acta Crystallogr A (1998) 1.21
Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer. J Clin Oncol (1999) 1.21
Evaluation of a psycho-educational group programme for family caregivers in home-based palliative care. Palliat Med (2008) 1.19
Limitations to plasticity of language network reorganization in localization related epilepsy. Brain (2008) 1.19
A population-based study of the coverage of cancer patients by hospice services. Palliat Med (1996) 1.18
Population-based study of prognostic factors in stage II colonic cancer. Br J Surg (2006) 1.16
EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer. Oncogene (1997) 1.08
Psychosocial issues in palliative care: the patient, the family, and the process and outcome of care. J Pain Symptom Manage (1995) 1.08
Metformin in prostate cancer: two for the price of one. Ann Oncol (2011) 1.07
Perceptions of symptom distress in lung cancer patients: I. Congruence between patients and primary family caregivers. J Pain Symptom Manage (1997) 1.06
Ethics in orthopaedic surgery. J Bone Joint Surg Br (2005) 1.06
Lack of association between duration of breast-feeding or introduction of cow's milk and development of islet autoimmunity. Diabetes (1999) 1.06
Characteristics of responding-, nonresponding- and refusing-parents in an adolescent lifestyle choice study. Eval Rev (2001) 1.05
Spontaneous rupture of the urinary bladder--delayed sequel of pelvic irradiation. A case report. S Afr Med J (1986) 1.04
Dyspnea in cancer patients: prevalence and associated factors. J Pain Symptom Manage (2001) 1.04
Skin reactions during radiotherapy for breast cancer: the use and impact of topical agents and dressings. Eur J Cancer Care (Engl) (1999) 1.03
Continuous passive motion after primary total knee arthroplasty. Does it offer any benefits? J Bone Joint Surg Br (1997) 1.02
Mechanism of oligonucleotide loop formation in solution. Biochemistry (1986) 1.01
Survey of Ehrlichia canis antibodies among dogs in Israel. Vet Rec (1996) 1.00
Ki-ras mutation type and the survival benefit from adjuvant chemotherapy in Dukes' C colorectal cancer. J Pathol (2001) 0.98
Conformation of the gramicidin A channel in phospholipid vesicles: a fluorine-19 nuclear magnetic resonance study. Biochemistry (1985) 0.98
Home versus hospital death: assessment of preferences and clinical challenges. CMAJ (1995) 0.98
Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis. Clin Cancer Res (1996) 0.97
Elevated stromal chondroitin sulfate glycosaminoglycan predicts progression in early-stage prostate cancer. Clin Cancer Res (1997) 0.95
The distribution of residual cancer in radical prostatectomy specimens in stage A prostate cancer. J Urol (1991) 0.94
Phantoms following breast amputation. Neuropsychologia (1970) 0.94
Relationship between p53 gene abnormalities and other tumour characteristics in breast-cancer prognosis. Int J Cancer (1996) 0.94
Carboplatin and gemcitabine in metastatic transitional cell carcinoma of the urothelium: effective treatment of patients with poor prognostic features. Ann Oncol (2001) 0.94
Analysis of p53 gene mutation by polymerase chain reaction-single strand conformation polymorphism provides independent prognostic information in node-negative breast cancer. Clin Cancer Res (1998) 0.93
A strategy to reduce inappropriate red blood cell transfusion. Med J Aust (1994) 0.92
Predicting the severity of radiation skin reactions in women with breast cancer. Oncol Nurs Forum (1998) 0.92
Low incidence of abnormal (18)FDG-PET in children with new-onset partial epilepsy: a prospective study. Neurology (2002) 0.92
Comparison of DVH data from multiple radiotherapy treatment planning systems. Phys Med Biol (2010) 0.92
Prevalence of non-specific health symptoms in South Australia. Int J Environ Health Res (2001) 0.91
Vimentin expression is not associated with poor prognosis in breast cancer. Int J Cancer (1996) 0.91
Neuroimaging of brain injury in neonates treated with extracorporeal membrane oxygenation: lessons learned from serial examinations. J Pediatr Surg (1994) 0.90
Carboplatin-paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer. Br J Cancer (2011) 0.90
Emergency brain computed tomography in children with seizures: who is most likely to benefit? J Pediatr (1998) 0.90
Prospective study of the prognostic significance of epidermal growth factor receptor in primary breast cancer. Int J Cancer (1996) 0.90
Three-dimensional image reconstruction from ordered arrays of 70S ribosomes. Biochimie (1987) 0.88
The suitability of multi-metal clusters for phasing in crystallography of large macromolecular assemblies. Structure (1996) 0.88
Paclitaxel as first-line treatment for metastatic breast cancer. The Taxol Investigational Trials Group, Australia and New Zealand. Oncology (Williston Park) (1997) 0.88
Models of integrated cancer care: a critique of the literature. Aust Health Rev (2000) 0.87
The relative prognostic significance of total cathepsin D and HER-2/neu oncogene amplification in breast cancer. The South Australian Breast Cancer Study Group. Int J Cancer (1994) 0.87
Development and testing of the ethical reasoning tool (ERT): an instrument to measure the ethical reasoning of nurses. J Adv Nurs (1997) 0.87
Adjunctive therapy with oxcarbazepine in children with partial seizures. The Oxcarbazepine Pediatric Study Group. Neurology (2000) 0.86
Age-related changes in hyaluronan, proteoglycan, collagen, and osteonectin synthesis by human bone cells. J Cell Physiol (1992) 0.86
Elevated levels of peritumoral chondroitin sulfate are predictive of poor prognosis in patients treated by radical prostatectomy for early-stage prostate cancer. Cancer Res (1999) 0.86
Use of a low-prime circuit for bloodless heart transplantation in xenotransplant of 5-7 kilogram primates. J Extra Corpor Technol (2000) 0.86
Environmental and genetic factors affecting transport of imatinib by OATP1A2. Clin Pharmacol Ther (2011) 0.86
Factors influencing the recurrence rate of bladder cancer. J Urol (1980) 0.85
Sleep respiratory instability in term neonates under hyperthermic conditions: age, sex, type of feeding, and rapid eye movements. Pediatr Res (1983) 0.85
Relationship between minimal residual disease and outcome in adult acute lymphoblastic leukemia. Blood (1996) 0.85
Characterization of a novel airway epithelial cell-specific short chain alcohol dehydrogenase/reductase gene whose expression is up-regulated by retinoids and is involved in the metabolism of retinol. J Biol Chem (2001) 0.85
Effects of local anesthetics on tactile sensitivity thresholds for cutaneous and mucous membranes. J Invest Dermatol (1977) 0.84
FDG-PET in children and adolescents with partial seizures: role in epilepsy surgery evaluation. Epilepsy Res (1995) 0.84
Progression of borderline increases in albuminuria in adolescents with insulin-dependent diabetes mellitus. Diabet Med (1997) 0.84
Use of fluorescent probes that form intramolecular excimers to monitor structural changes in model and biological membranes. Biophys J (1981) 0.84
Photochemically induced nuclear polarization study of the accessibility of tyrosines in insulin. Biochemistry (1984) 0.83
Stature, head height, and growth of the vertical face. Am J Orthod (1983) 0.83
Transthoracic, transdiaphragmatic excision of simultaneous lung and adrenal lesions. Ann Thorac Surg (1998) 0.83
Research related to malocclusion. A "State-of-the-Art" workshop conducted by the Oral-Facial Growth and Development Program, The National Institute of Dental Research. Am J Orthod (1971) 0.83
Ataxia telangiectasia with hepatocellular carcinoma in a 15-year-old girl and studies of her kindred. Arch Pathol Lab Med (1985) 0.83
Targeting exposed RNA regions in crystals of the small ribosomal subunits at medium resolution. Cell Mol Biol (Noisy-le-grand) (2000) 0.82
Management of radiation skin reactions: literature review and clinical application. Plast Surg Nurs (1999) 0.82
Relationship between the electrical (electrocardiographic) and mechanical (echocardiographic) events in Wolff-Parkinson-White syndrome. Chest (1977) 0.82
Brompheniramine, loratadine, and placebo in allergic rhinitis: a placebo-controlled comparative clinical trial. J Clin Pharmacol (1998) 0.82
Morphologic analysis of upper lip area following maxillary osteotomy via the tunneling approach. Am J Orthod (1984) 0.82
Four-year experience with exclusive use of cytomegalovirus antibody (CMV-Ab)-negative donors for CMV-Ab-negative kidney recipients. Transplant Proc (1988) 0.81
Palliative care in Western Australia: an assessment of information and support needs. Int J Palliat Nurs (2001) 0.81
Adaptive growth changes of the gonial region in Macaca mulatta. Am J Phys Anthropol (1971) 0.81
Gas chromatographic determination of the configuration of alanine and serine in staphylococcal cell walls. Biochim Biophys Acta (1970) 0.81
Physical properties of human lips: experimental and theoretical analysis. J Biomech (1982) 0.81
Dose intensity in cancer chemotherapy. Br J Cancer (1990) 0.81